Functional polymorphism in human CYP4F2 decreases 20-HETE production

Physiological Genomics

Volumn 30, Issue 1, 2007, Pages 74-81

  Stec, David E ^a   Roman, Richard J ^b   Flasch, Averia ^b   Rieder, Mark J ^c  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

20 hydroxyeicosatetraenoic acid; Cytochrome P450; Leukotriene B 4; Variant

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; LEUKOTRIENE B4; 20 HYDROXY 5,8,11,14 EICOSATETRAENOIC ACID; 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; ARACHIDONIC ACID; CYP4F2 PROTEIN, HUMAN; CYTOCHROME P450; HYDROXYICOSATETRAENOIC ACID; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ARTICLE; BACULOVIRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOCHROME P450 4F2 GENE; DNA POLYMORPHISM; DNA SEQUENCE; EUROPEAN AMERICAN; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; HUMAN; HYDROXYLATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; ARMYWORM; CAUCASIAN; CELL LINE; ENZYMOLOGY; GENE EXPRESSION; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MASS SPECTROMETRY; METABOLISM; WESTERN BLOTTING;

HEXAPODA;

AFRICAN AMERICANS; ANIMALS; ARACHIDONIC ACID; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE EXPRESSION; GENE FREQUENCY; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; LEUKOTRIENE B4; LINKAGE DISEQUILIBRIUM; MASS SPECTROMETRY; MICROSOMES, LIVER; POLYMORPHISM, SINGLE NUCLEOTIDE; SPODOPTERA;

EID: 34447266926     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00003.2007     Document Type: Article

References (32)

1. Bylund J, Bylund M, Oliw EH. cDNA cloning and expression of CYP4F12, a novel human cytochrome P450. Biochem Biophys Res Commun 280: 892-897, 2001.
2. Bylund J, Harder AG, Maier KG, Roman RJ, Harder DR. Leukotriene B4 omega-side chain hydroxylation by CYP4F5 and CYP4F6. Arch Biochem Biophys 412: 34-41, 2003.
3. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74: 106-120, 2004.
4. Copeland WC, Wang TS. Mutational analysis of the human DNA polymerase alpha. The most conserved region in alpha-like DNA polymerases is involved in metal-specific catalysis. J Biol Chem 268: 11028-11040, 1993.
5. Crooks SW, Stockley RA. Leukotriene B4. Int J Biochem Cell Biol 30: 173-178, 1998.
6. Escalante B, Erlij D, Falck JR, McGiff JC. Effect of cytochrome-P450 arachidonate metabolites on ion-transport in rabbit kidney loop of Henle. Science 251: 799-802, 1991.
7. Gainer JV, Bellamine A, Dawson EP, Womble KE, Grant SW, Wang Y, Cupples LA, Guo CY, Demissie S, O'Donnell CJ, Brown NJ, Waterman MR, Capdevila JH. Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation 111: 63-69, 2005.
8. Hoagland KM, Flasch AK, Roman RJ. Inhibitors of 20-HETE formation promote salt-sensitive hypertension in rats. Hypertension 42: 669-673, 2003.
9. Honeck H, Gross V, Erdmann B, Kargel E, Neunaber R, Milia AF, Schneider W, Luft FC, Schunck WH. Cytochrome P450-dependent renal arachidonic acid metabolism in desoxycorticosterone acetate-salt hypertensive mice. Hypertension 36: 610-616, 2000.
10. Ito O, Roman RJ. Role of 20-HETE in elevating chloride transport in the thick ascending limb of Dahl SS/Jr rats. Hypertension 33: 419-423, 1999.
11. Jin R, Koop DR, Raucy JL, Lasker JM. Role of human CYP4F2 in hepatic catabolism of the proinflammatory agent leukotriene B4. Arch Biochem Biophys 359: 89-98, 1998.
12. King LM, Ma J, Srettabunjong S, Graves J, Bradbury JA, Li L, Spiecker M, Liao JK, Mohrenweiser H, Zeldin DC. Cloning of CYP2J2 gene and identification of functional polymorphisms. Mol Pharmacol 61:840-852, 2002.
13. Laffer CL, Laniado-Schwartzman M, Wang MH, Nasjletti A, Elijovich F. 20-HETE and furosemide-induced natriuresis in salt-sensitive essential hypertension. Hypertension 41: 703-708, 2003.
14. Laffer CL, Laniado-Schwartzman M, Wang MH, Nasjletti A, Elijovich F. Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic Acid in human salt-sensitive versus salt-resistant hypertension. Circulation 107: 574-578, 2003.
15. Lasker JM, Chen WB, Wolf I, Bloswick BP, Wilson PD, Powell PK. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney - role of CYP4F2 and CYP4A11. J Biol Chem 275: 4118-4126, 2000.
16. Ma YH, Schwartzman ML, Roman RJ. Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 267: R579-R589, 1994.
17. Maier KG, Henderson L, Narayanan J, Alonso-Galicia M, Falck JR, Roman RJ. Fluorescent HPLC assay for 20-HETE and other P-450 metabolites of arachidonic acid. Am J Physiol Heart Circ Physiol 279: H863-H871, 2000.
18. Mayer B, Lieb W, Gotz A, Konig IR, Aherrahrou Z, Thiemig A, Holmer S, Hengstenberg C, Doering A, Loewel H, Hense HW, Schunkert H, Erdmann J. Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy. Hypertension 46: 766-771, 2005.
19. Mayer B, Lieb W, Gotz A, Konig IR, Kauschen LF, Linsel-Nitschke P, Pomarino A, Holmer S, Hengstenberg C, Doering A, Loewel H, Hense HW, Ziegler A, Erdmann J, Schunkert H. Association of a functional polymorphism in the CYP4A11 gene with systolic blood pressure in survivors of myocardial infarction. J Hypertens 24: 1965-1970, 2006.
20. +-ATPase through a cytochrome P-450 pathway. Am J Physiol Renal Fluid Electrolyte Physiol 266: F497-F505, 1994.
21. Roman RJ, Hoagland KM, Lopez B, Kwitek AE, Garrett MR, Rapp JP, Lazar J, Jacob HJ, Sarkis A. Characterization of blood pressure and renal function in chromosome 5 congenic strains of Dahl S rats. Am J Physiol Renal Physiol 290: F1463-F1471, 2006.
22. Roman RJ, Ma YH, Frohlich B, Markham B. Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats. Hypertension 21: 985-988, 1993.
23. Sanchez-Mendoza A, Lopez-Sanchez P, Vazquez-Cruz B, Rios A, Martinez-Ayala S, Escalante B. Angiotensin II modulates ion transport in rat proximal tubules through CYP metabolites. Biochem Biophys Res Commun 272: 423-430, 2000.
24. Shatara RK, Quest DW, Wilson TW. Fenofibrate lowers blood pressure in two genetic models of hypertension. Can J Physiol Pharmacol 78: 367-371, 2000.
25. Stec DE, Deng AY, Rapp JP, Roman RJ. Cytochrome P4504A genotype cosegregates with hypertension in Dahl S rats. Hypertension 27: 564-568, 1996.
26. Stec DE, Mattson DL, Roman RJ. Inhibition of renal outer medullary 20-HETE production produces hypertension in Lewis rats. Hypertension 29: 315-319, 1997.
27. Tager AM, Luster AD. BLT1 BLT2: the leukotriene B(4) receptors. Prostaglandins Leukot Essent Fatty Acids 69: 123-134, 2003.
28. Vera T, Taylor M, Bohman Q, Flasch A, Roman RJ, Stec DE. Fenofibrate prevents the development of angiotensin II-dependent hypertension in mice. Hypertension 45: 730-735, 2005.
29. Wang MH, Zhang F, Marji J, Zand BA, Nasjletti A, Laniado-Schwartzman M. CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR. Am J Physiol Regul Integr Comp Physiol 280: R255-R261, 2001.
30. Zhou Y, Huang H, Chang HH, Du J, Wu JF, Wang CY, Wang MH. Induction of renal 20-hydroxyeicosatetraenoic acid by clofibrate attenuates high-fat diet-induced hypertension in rats. J Pharmacol Exp Ther 317: 11-18, 2006.
31. Zou AP, Drummond HA, Roman RJ. Role of 20-HETE in elevating loop chloride reabsorption in Dahl SS/Jr rats. Hypertension 27: 631-635, 1996.
32. + channel in renal arterioles. Am J Physiol Regul Integr Comp Physiol 270: R228-R237, 1996.